Brownson RC, Samet JM, Chavez GF, Davies MM, Galea S, Hiatt RA, et al. Charting a future for epidemiologic training. Ann Epidemiol. 2015;25(6):458–65. [Twelve macro trends for epidemiology providing the context for SF CAN].
Hiatt RA. Invited commentary: The epicenter of translational science. Am J Epidemiol. 2010;172(5):525–7 (discussion 8-9).
Hiatt RA, Sibley A, Fejerman L, Glantz S, Nguyen T, Pasick R, et al. The San Francisco Cancer Initiative: a community effort to reduce the population burden of cancer. Health Aff. 2018;37(1):54–61. [A detailed baseline description of SF CAN with all logic models and partners appended].
California Department of Public Health. Center for Health Statistics Death Master Files. California all cause mortality 1970-2014.
Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;Spec No:80-94.
Braveman P, Gottlieb L. The social determinants of health: it’s time to consider the causes of the causes. Public Health Rep. 2014;129(Suppl 2):19–31. [A focus on the upstream causes of health and disease and the actions needed to address them].
Kania J, Kramer M. Collective Impact. Stanf Soc Innov Rev. 2011;9(1):36–41.
Ciesielski TH, Aldrich MC, Marsit CJ, Hiatt RA, Williams SM. Transdisciplinary approaches enhance the production of translational knowledge. Transl Res: J Lab Clin Med. 2017;182:123–34.
Gomez SL CI, Shariff-Marco S, Davidson-Allen, K. The Greater Bay Area Cancer Registry. Incidence and Mortality Annual Review, 1988-2017. University of California, San Francisco; 2020.
DataSF. COVID-19 cases and deaths: San Francisco Department of Public Health; 2021 [Available from: https://data.sfgov.org/stories/s/dak2-gvuj.
Registry GBACR. California Health Maps: Greater Bay Area Cancer Registry; 2021 [Available from: www.californiahealthmaps.org.
Rivadeneira NA, Hoskote M, Le GM, Nguyen TT, Nápoles AM, Pasick RJ, et al. Advancing cancer control in San Francisco: cancer screening in under-represented populations. Am J Prev Med. 2020;58(1):e1–9.
Cole H, Schoenthaler A, Braithwaite RS, Ladapo J, Mentor S, Uyei J, et al. Community-based settings and sampling strategies: implications for reducing racial health disparities among black men, New York City, 2010–2013. Prev Chronic Dis. 2014;11:E105.
Santiago-Rodríguez EJ, Rivadeneira NA, Torres JM, Sarkar U, Hiatt RA. Socioeconomic status and colorectal cancer screening behaviors in a vulnerable multiethnic population. Ethn & Health. 2020;0(0):1–17.
Khoong EC, Le G, Hoskote M, Rivadeneira N, Hiatt RA, Sarkar U. Health information seeking behaviors and preferences of a diverse multi-lingual cohort. Med Care. 2019;57(Suppl 6 2):S176–83.
Khoong EC, Rivadeneira NA, Hiatt RA, Sarkar U. The use of technology for communicating with clinicians or seeking health information in a multilingual urban cohort: cross-sectional survey. J Med Internet Res. 2020;22(4):e16951.
Barrett NJ, Rodriguez EM, Iachan R, Hyslop T, Ingraham KL, Le GM, et al. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers. Cancer. 2020;126(5):1077–89.
Green LW, Kreuter MW. Health program planning: an educational and ecological approach. New York: McGraw-Hill; 2005.
U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Prevent Service Task Force. 2009;151(10):716–26.
Karliner LS, Ma L, Hofmann M, Kerlikowske K. Language barriers, location of care, and delays in follow-up of abnormal mammograms. Med Care. 2012;50(2):171–8.
Nguyen KH, Pasick RJ, Stewart SL, Kerlikowske K, Karliner LS. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups. Cancer. 2017;123(18):3468–75.
Guan A, Lichtensztajn D, Oh D, Jain J, Tao L, Hiatt RA, et al. Breast cancer in San Francisco: disentangling disparities at the neighborhood level. Cancer Epidemiol Biomarkers Prev. 2019;28(12):1968–76.
SF CAN. The San Francisco Cancer Initiative 2021. [Available from: www.sfcancer.org.
Velazquez AI, Wong L, Dugatkin T, Bo BD Fejerman L. Teens for screens: implementation of a breast cancer awareness education program among high school students from minority communities in San Francisco. Cancer Epidemiol Biomarkers Prev.(Abstract PO-052) 2020. https://doi.org/10.1158/1538-7755.DISP20-PO-052.
Sawdey MD, Chang JT, Cullen KA, Rass O, Jackson KJ, Ali FRM, et al. Trends and associations of menthol cigarette smoking among US middle and high school students-National Youth Tobacco Survey, 2011–2018. Nicotine Tob Res. 2020;22(10):1726–35.
Gardiner PS. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res. 2004;6(Suppl 1):S55-65.
Fallin A, Goodin AJ, King BA. Menthol cigarette smoking among lesbian, gay, bisexual, and transgender adults. Am J Prev Med. 2015;48(1):93–7.
Vyas P, Ling P, Gordon B, Callewaert J, Dang A, Smith D, et al. Compliance with San Francisco’s flavoured tobacco sales prohibition. Tob Control. 2021;30(2):227–30.
Vijayaraghavan M, Elser H, Frazer K, Lindson N, Apollonio D. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database of Syst Rev. 2020(12).
Vijayaraghavan M, Apollonio DE. Engaging adults experiencing homelessness in smoking cessation through large-scale community service events. Health Promot Pract. 2019;20(3):325–7.
Holmes LM, Lea Watkins S, Lisha NE, Ling PM. Does experienced discrimination explain patterns of menthol use among young adults? Evidence from the 2014 San Francisco Bay Area Young Adult Health Survey. Subst Use Misuse. 2019;54(7):1106–14.
Watkins SL, Thrul J, Max W, Ling PM. Cold Turkey and Hot Vapes? A national study of young adult cigarette cessation strategies. Nicotine Tob Res. 2020;22(5):638–46.
Nguyen N, Lisha NE, Neilands TB, Jordan JW, Ling PM. Differential associations between anti-tobacco industry attitudes and intention to quit smoking across young adult peer crowds. Am J Health Promot. 2019;33(6):876–85.
Tsodikov A, Gulati R, de Carvalho TM, Heijnsdijk EAM, Hunter-Merrill RA, Mariotto AB, et al. Is prostate cancer different in black men? Answers from 3 natural history models. Cancer. 2017;123(12):2312–9.
Cooperberg MR, Carroll PR, Dall’Era MA, Davies BJ, Davis JW, Eggener SE, et al. The state of the science on prostate cancer biomarkers: the San Francisco consensus statement. Eur Urol. 2019;76(3):268–72.
Cooperberg MR, Lin DW. Active surveillance for prostate cancer: a 2020 vision. Eur Urol. 2020;77(6):687–8.
Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Prevent Service Task Force. 2002;137(11):917–29.
Bibbins-Domingo K, Grossman DC, Curry SJ. The US Preventive Services Task Force 2017 draft recommendation statement on screening for prostate cancer: an invitation to review and comment. JAMA. 2017;317(19):1949–50.
Davis-Paterson SKS, Miguelina-Keasling V, Surani V. California’s Comprehensive Cancer Control Plan, 2021–2025. Sacramento, CA: California Department of Public Health; 2021.
Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Service Task Force. Ann Intern Med. 2002;137(2):132–41.
Issaka RB, Avila P, Whitaker E, Bent S, Somsouk M. Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: a systematic review. Prev Med. 2019;118:113–21.
Issaka RB, Rachocki C, Huynh MP, Chen E, Somsouk M. Standardized workflows improve colonoscopy follow-up after abnormal fecal immunochemical tests in a safety-net system. Dig Dis Sci. 2021;66(3):768–74.
Wang A, Lee B, Patel S, Whitaker E, Issaka RB, Somsouk M. Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: a systematic review. J Med Screen. 2021:0969141321997482.
Wang A, Rachocki C, Shapiro JA, Issaka RB, Somsouk M. Low literacy level instructions and reminder calls improve patient handling of fecal immunochemical test samples. Clin Gastroenterol Hepatol. 2019;17(9):1822–8.
Salvatore M, Jeon J, Meza R. Changing trends in liver cancer incidence by race/ethnicity and sex in the US: 1992–2016. Cancer Causes Control. 2019;30(12):1377–88.
End HepC SF 2021. [Available from: https://endhepcsf.org/.
Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, et al. Estimated hepatitis C prevalence and key population sizes in San Francisco: a foundation for elimination. PloS One. 2018;13(4):e0195575.
Rechis R, Oestman KB, Caballero E, Brewster A, Walsh MT, Basen-Engquist K, et al. Be Well Communities™: mobilizing communities to promote wellness and stop cancer before it starts. Cancer Causes Control. 2021;32(8):859–70.
Simon MA, Fitzgibbon M, Ciecierski C, Cooper JM, Martinez E, Tom L, et al. Building cross-institutional collaborative infrastructure and processes: early lessons from the Chicago Cancer Health Equity Collaborative. Prog Community Health Partnersh. 2019;13(5):5–13.
Giachello AL, Watson KS, Stuart M, Barceló H, Glenn J, Wang S, et al. Community-academic partnerships to reduce cancer inequities: the Chicago CHEC Community Engagement Core. Prog Community Health Partnersh. 2019;13(5):21–37.
The Kraft Center. Implementation Science Center for Cancer Control Equity (ISCCCE): Massachusetts General Hospital; 2021 [Available from: http://www.kraftcommunityhealth.org/programs/cancer-care-equity/.
Barrett NJ, Ingraham KL, Bethea K, Hwa-Lin P, Chirinos M, Fish LJ, et al. Project PLACE: enhancing community and academic partnerships to describe and address health disparities. Adv Cancer Res. 2020;146:167–88.
State NY. New York State Department of Health; 2021 [Available from: https://www.health.ny.gov/diseases/cancer/prevention_in_action/.
Ohio Colorectal Cancer Prevention Initiative (OCCPI: The Ohio State University Comprehensive Cancer Center. 2021. [Available from: https://cancer.osu.edu/our-impact/community-outreach-and-engagement/statewide-initiatives/statewide-colon-cancer-initiative.
Latinos United for Cancer Health Advancement (LUCHA) UC Davis Health Comprehensive Cancer Center.; 2021 [Available from: https://health.ucdavis.edu/cancer/research/programs/iniciativalatina/index.html.
Brownson RC, Colditz GA, K. PE, editors. Dissemination and implementation research in health: translating science to practice. . New York: Oxford University Press; 2012.
Issaka RB, Somsouk M. Colorectal cancer screening and prevention in the COVID-19 era. JAMA Health Forum. 2020;1(5):e200588.